REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/24/2025
Back to search
Official data from USPTO
TEMFERON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
03/25/2025
Trademark type
Word
Nice classes
5, 42
Filing date
01/17/2019
Registration date
03/24/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2020
Last transaction
03/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IT
Examiner
BUTTON, JENNIFER
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genenta Science S.r.l.
Representatives
Bradley D. Crose Crose Law LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal alcohol; medicinal drinks; medicinal infusions for treating cancer; diagnostic preparations for medical purposes; pharmaceutical preparations for the treatment of cancer; nutritionally fortified beverages for medical purposes; medicinal preparations for the treatment of infectious diseases; pharmaceutical preparations and substances for oncology cancer treatment; pharmaceutical preparations and substancesanti-inflammatories; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for use in the field of anesthesiaanesthetics; medicated body lotions for skin; medicinal preparations for treating cancer; biochemical preparations for treating cancer for medical purposes; biotechnological preparations for treating cancer for medical purposes; medicated bath preparations for therapeutic use; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for use in chemotherapy; agents for the reduction of tumors; medications used for the treatment of cancer; pharmaceutical preparations for the treatment of malignant tumor; medicines to treat cancer; medical preparations for the treatment of cancer; pharmaceutical preparations and substances for the treatment and prevention of cancer; pharmaceutical products for the treatment of cancer; preparations for medical purposes used for the detection of genetic mutations; preparations for medical purposes used for the detection of genetic predisposition
Class 42
Medical research; design and development of medical technology; conducting clinical trials for others; services related to medical researchpharmacological and biological research; clinical research; human tissues analysis for medical research purposes; design and development of equipment in the field of medical research; providing information related to scientific and medical research in the sector of pharmaceutical and clinical experimentation; conducting of clinical experiments related to the field of therapies; research in the field of genetic therapies; consultancy in the field of genetic therapies for scientific research purposes
Publications
History of USPTO decisions and trademark events.
26 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/25/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/30/2020
FIMP
FINAL DISPOSITION PROCESSED
07/30/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/24/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2020
PUBO
PUBLISHED FOR OPPOSITION
01/07/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/04/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/18/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/18/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2019
ALIE
ASSIGNED TO LIE
11/25/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/20/2019
RFNT
REFUSAL PROCESSED BY IB
09/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/22/2019
RFRR
REFUSAL PROCESSED BY MPU
08/22/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/27/2019
CNRT
NON-FINAL ACTION WRITTEN
07/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
07/20/2019
DOCK
ASSIGNED TO EXAMINER
07/16/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/16/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/11/2019
Continuous trademark protection
Get notified about every new filing that threatens TEMFERON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.